Emory University’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History
Bought
Maintained
Sold
Other funds holding ANAC
BBA
PAI
BFA
VM
EAM
RCP
Emory University's ANAC Position: Q3 2015 in Review
Emory University reduced its ANACOR PHARMACEUTICALS INC COM (ANAC) stake by 54% in Q3 2015, selling an estimated $1.69M and leaving 11,096 shares worth $1.31M. The position accounts for 3.64% of the portfolio, ranked #12.
Emory University first reported a position in ANAC in Q1 2015 and has held it in 3 quarters since. The position peaked at $1.86M in Q2 2015. 213 funds tracked by Wall St. Rank hold ANAC as of Q3 2015.
- Emory University held 11,096 shares of ANACOR PHARMACEUTICALS INC COM worth $1.31M as of Q3 2015.
- Emory University sold 12,957 ANACOR PHARMACEUTICALS INC COM shares in Q3 2015, an estimated $1.69M.
- ANACOR PHARMACEUTICALS INC COM made up 3.64% of Emory University's portfolio in Q3 2015, its #12 holding.
- Emory University first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2015 and has held it in 3 quarters since.
- Emory University's ANACOR PHARMACEUTICALS INC COM position peaked at $1.86M in Q2 2015.
- 213 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q3 2015.
Based on Emory University's 13F filing for Q3 2015, filed 16 Nov 2015.